| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 5.65e-06 | 130 | 105 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | TUBB8 TUBB TUBB2B RAB44 TUBB2A TUBB6 TUBB4A TUBB4B RHOBTB2 RAPGEF2 GMPPB | 1.99e-05 | 439 | 105 | 11 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | TUBB8 TUBB TUBB2B RAB44 TUBB2A TUBB6 TUBB4A TUBB4B RHOBTB2 RAPGEF2 GMPPB | 1.99e-05 | 439 | 105 | 11 | GO:0019001 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | PRUNE2 ABCA3 TUBB8 TUBB TUBB2B SMARCAD1 RAB44 ABCA9 TUBB2A TUBB6 TUBB4A TUBB4B RHOBTB2 NAV1 HSP90AA4P | 3.24e-05 | 839 | 105 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | PRUNE2 ABCA3 TUBB8 TUBB TUBB2B SMARCAD1 RAB44 ABCA9 TUBB2A TUBB6 TUBB4A TUBB4B RHOBTB2 NAV1 HSP90AA4P | 3.29e-05 | 840 | 105 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | PRUNE2 ABCA3 TUBB8 TUBB TUBB2B SMARCAD1 RAB44 ABCA9 TUBB2A TUBB6 TUBB4A TUBB4B RHOBTB2 NAV1 HSP90AA4P | 3.29e-05 | 840 | 105 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | GTP binding | TUBB8 TUBB TUBB2B RAB44 TUBB2A TUBB6 TUBB4A TUBB4B RHOBTB2 GMPPB | 4.64e-05 | 397 | 105 | 10 | GO:0005525 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA3 TUBB8 TUBB TUBB2B SMARCAD1 RAB44 ABCA9 TUBB2A TUBB6 TUBB4A TUBB4B RHOBTB2 NAV1 HSP90AA4P | 5.44e-05 | 775 | 105 | 14 | GO:0017111 |
| GeneOntologyMolecularFunction | GTPase activity | 7.92e-05 | 341 | 105 | 9 | GO:0003924 | |
| GeneOntologyMolecularFunction | acetylcholine receptor regulator activity | 3.77e-04 | 27 | 105 | 3 | GO:0030548 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor regulator activity | 4.21e-04 | 28 | 105 | 3 | GO:0099602 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 9.64e-04 | 37 | 105 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.39e-03 | 231 | 105 | 6 | GO:0005085 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.51e-03 | 320 | 105 | 7 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.68e-03 | 326 | 105 | 7 | GO:0001217 | |
| GeneOntologyCellularComponent | intercellular bridge | 2.41e-08 | 94 | 105 | 8 | GO:0045171 | |
| GeneOntologyCellularComponent | mitotic spindle | 7.03e-05 | 201 | 105 | 7 | GO:0072686 | |
| GeneOntologyCellularComponent | tubulin complex | 7.47e-05 | 3 | 105 | 2 | GO:0045298 | |
| HumanPheno | Low anterior hairline | 2.45e-05 | 147 | 43 | 8 | HP:0000294 | |
| HumanPheno | Gowers sign | 4.12e-05 | 78 | 43 | 6 | HP:0003391 | |
| HumanPheno | Congenital abnormal hair pattern | TBX15 FAT4 FOS GATA1 HUWE1 PPARG ARID1A MEGF8 RHOBTB2 SMARCA2 HERC2 | 5.77e-05 | 327 | 43 | 11 | HP:0011361 |
| HumanPheno | Abnormality of the frontal hairline | 5.79e-05 | 215 | 43 | 9 | HP:0000599 | |
| HumanPheno | Abnormal neck morphology | TBX15 FLNC FOS SYNE1 TUBB GATA1 TUBB2B HUWE1 PPARG SELENON HPDL RYR1 TUBB4A MEGF8 SCN4A SMARCA2 GMPPB | 7.67e-05 | 766 | 43 | 17 | HP:0025668 |
| Domain | Beta-tubulin_BS | 1.39e-14 | 10 | 102 | 7 | IPR013838 | |
| Domain | Beta_tubulin | 1.39e-14 | 10 | 102 | 7 | IPR002453 | |
| Domain | TUBULIN_B_AUTOREG | 3.81e-14 | 11 | 102 | 7 | PS00228 | |
| Domain | - | 8.60e-12 | 20 | 102 | 7 | 3.30.1330.20 | |
| Domain | - | 1.28e-11 | 21 | 102 | 7 | 1.10.287.600 | |
| Domain | Tubulin_C | 1.87e-11 | 22 | 102 | 7 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 1.87e-11 | 22 | 102 | 7 | IPR018316 | |
| Domain | - | 1.87e-11 | 22 | 102 | 7 | 3.40.50.1440 | |
| Domain | Tubulin_C | 1.87e-11 | 22 | 102 | 7 | SM00865 | |
| Domain | Tub_FtsZ_C | 2.68e-11 | 23 | 102 | 7 | IPR008280 | |
| Domain | Tubulin_C | 2.68e-11 | 23 | 102 | 7 | IPR023123 | |
| Domain | TUBULIN | 2.68e-11 | 23 | 102 | 7 | PS00227 | |
| Domain | Tubulin | 2.68e-11 | 23 | 102 | 7 | IPR000217 | |
| Domain | Tubulin | 2.68e-11 | 23 | 102 | 7 | SM00864 | |
| Domain | Tubulin_CS | 2.68e-11 | 23 | 102 | 7 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 3.77e-11 | 24 | 102 | 7 | IPR003008 | |
| Domain | Tubulin | 3.77e-11 | 24 | 102 | 7 | PF00091 | |
| Domain | Spy1 | 2.53e-05 | 11 | 102 | 3 | PF11357 | |
| Domain | Speedy | 2.53e-05 | 11 | 102 | 3 | IPR020984 | |
| Domain | IGv | 7.57e-04 | 75 | 102 | 4 | SM00406 | |
| Domain | PDZ | 1.06e-03 | 141 | 102 | 5 | PF00595 | |
| Domain | PDZ | 1.31e-03 | 148 | 102 | 5 | SM00228 | |
| Domain | - | 1.39e-03 | 150 | 102 | 5 | 2.30.42.10 | |
| Domain | PDZ | 1.43e-03 | 151 | 102 | 5 | PS50106 | |
| Domain | PDZ | 1.48e-03 | 152 | 102 | 5 | IPR001478 | |
| Domain | ABC_A | 1.88e-03 | 12 | 102 | 2 | IPR026082 | |
| Domain | - | 2.22e-03 | 13 | 102 | 2 | 1.20.58.280 | |
| Domain | MIT | 2.57e-03 | 14 | 102 | 2 | IPR007330 | |
| Domain | Rib_L2_dom2 | 4.27e-03 | 18 | 102 | 2 | IPR014722 | |
| Domain | - | 4.27e-03 | 18 | 102 | 2 | 2.30.30.30 | |
| Domain | UBA-like | 5.18e-03 | 64 | 102 | 3 | IPR009060 | |
| Domain | RCC1 | 5.26e-03 | 20 | 102 | 2 | PF00415 | |
| Domain | RCC1_1 | 5.80e-03 | 21 | 102 | 2 | PS00625 | |
| Domain | RCC1_2 | 5.80e-03 | 21 | 102 | 2 | PS00626 | |
| Domain | RCC1_3 | 5.80e-03 | 21 | 102 | 2 | PS50012 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.02e-12 | 17 | 70 | 7 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.67e-12 | 18 | 70 | 7 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.63e-12 | 19 | 70 | 7 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.63e-12 | 19 | 70 | 7 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 4.03e-12 | 20 | 70 | 7 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 4.03e-12 | 20 | 70 | 7 | M47911 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 6.02e-12 | 21 | 70 | 7 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 8.79e-12 | 22 | 70 | 7 | M47903 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 1.26e-11 | 23 | 70 | 7 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 1.26e-11 | 23 | 70 | 7 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 1.77e-11 | 24 | 70 | 7 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.77e-11 | 24 | 70 | 7 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 2.45e-11 | 25 | 70 | 7 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.45e-11 | 25 | 70 | 7 | M47710 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 3.34e-11 | 26 | 70 | 7 | M47672 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 5.96e-11 | 28 | 70 | 7 | M47898 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 2.11e-10 | 33 | 70 | 7 | M47901 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 3.30e-10 | 35 | 70 | 7 | M47774 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 6.16e-10 | 21 | 70 | 6 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.53e-09 | 43 | 70 | 7 | M47669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 1.53e-09 | 43 | 70 | 7 | M47773 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 2.14e-09 | 45 | 70 | 7 | M47670 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 5.23e-09 | 29 | 70 | 6 | M27948 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 9.20e-09 | 55 | 70 | 7 | M39613 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 9.86e-09 | 32 | 70 | 6 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 9.86e-09 | 32 | 70 | 6 | M27491 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.05e-08 | 56 | 70 | 7 | M2333 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.54e-08 | 17 | 70 | 5 | MM14731 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 2.93e-08 | 38 | 70 | 6 | M14981 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 5.66e-08 | 71 | 70 | 7 | M39690 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 6.24e-08 | 72 | 70 | 7 | M26954 | |
| Pathway | REACTOME_AGGREPHAGY | 7.33e-08 | 44 | 70 | 6 | M29830 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 7.33e-08 | 44 | 70 | 6 | M27934 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 8.20e-08 | 23 | 70 | 5 | M19135 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 9.65e-08 | 46 | 70 | 6 | M27828 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.42e-07 | 49 | 70 | 6 | M891 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 1.58e-07 | 26 | 70 | 5 | M9648 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.82e-07 | 51 | 70 | 6 | M26972 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.94e-07 | 27 | 70 | 5 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.94e-07 | 27 | 70 | 5 | MM15674 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.30e-07 | 53 | 70 | 6 | M27651 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 2.83e-07 | 29 | 70 | 5 | MM15219 | |
| Pathway | KEGG_GAP_JUNCTION | 2.95e-07 | 90 | 70 | 7 | M4013 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 3.58e-07 | 57 | 70 | 6 | M27251 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 4.28e-07 | 95 | 70 | 7 | M6729 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 4.74e-07 | 32 | 70 | 5 | MM14730 | |
| Pathway | REACTOME_KINESINS | 5.40e-07 | 61 | 70 | 6 | M977 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 5.56e-07 | 33 | 70 | 5 | M27297 | |
| Pathway | REACTOME_AGGREPHAGY | 8.74e-07 | 36 | 70 | 5 | MM15669 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.01e-06 | 37 | 70 | 5 | MM15102 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 2.00e-06 | 76 | 70 | 6 | M48037 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 2.00e-06 | 76 | 70 | 6 | M27215 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.21e-06 | 121 | 70 | 7 | M872 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 2.44e-06 | 44 | 70 | 5 | MM14606 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 2.52e-06 | 79 | 70 | 6 | M27743 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 3.79e-06 | 48 | 70 | 5 | MM15353 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 5.30e-06 | 138 | 70 | 7 | M29805 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 5.40e-06 | 90 | 70 | 6 | M29841 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 5.40e-06 | 90 | 70 | 6 | MM14979 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 5.66e-06 | 52 | 70 | 5 | MM14949 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 5.66e-06 | 52 | 70 | 5 | MM15211 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 6.34e-06 | 200 | 70 | 8 | M864 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | 6.58e-06 | 201 | 70 | 8 | M27472 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 6.84e-06 | 54 | 70 | 5 | M27482 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 6.96e-06 | 94 | 70 | 6 | M2843 | |
| Pathway | REACTOME_KINESINS | 8.95e-06 | 57 | 70 | 5 | MM15714 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 9.95e-06 | 100 | 70 | 6 | M27650 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.12e-05 | 102 | 70 | 6 | M27648 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 1.19e-05 | 156 | 70 | 7 | M27097 | |
| Pathway | REACTOME_HCMV_INFECTION | 1.52e-05 | 162 | 70 | 7 | M29804 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.85e-05 | 66 | 70 | 5 | MM17074 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 2.07e-05 | 170 | 70 | 7 | M941 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 2.14e-05 | 68 | 70 | 5 | MM14921 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.14e-05 | 68 | 70 | 5 | MM14968 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 2.33e-05 | 116 | 70 | 6 | MM15715 | |
| Pathway | REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS | 2.50e-05 | 12 | 70 | 3 | M27738 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 3.02e-05 | 73 | 70 | 5 | MM15491 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 3.02e-05 | 73 | 70 | 5 | MM15672 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 3.45e-05 | 184 | 70 | 7 | MM15145 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 3.72e-05 | 126 | 70 | 6 | M705 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 3.83e-05 | 187 | 70 | 7 | M961 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 3.89e-05 | 127 | 70 | 6 | M27181 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 4.34e-05 | 261 | 70 | 8 | M42565 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 5.25e-05 | 134 | 70 | 6 | M27751 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 6.64e-05 | 204 | 70 | 7 | M4217 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 6.70e-05 | 140 | 70 | 6 | M27550 | |
| Pathway | WP_SELENIUM_METABOLISM_SELENOPROTEINS | 7.12e-05 | 45 | 70 | 4 | MM15877 | |
| Pathway | WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS | 8.46e-05 | 47 | 70 | 4 | M48301 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | 9.79e-05 | 217 | 70 | 7 | MM14708 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 1.02e-04 | 94 | 70 | 5 | MM14515 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 1.02e-04 | 151 | 70 | 6 | M550 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | 1.07e-04 | 297 | 70 | 8 | M27050 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.24e-04 | 98 | 70 | 5 | MM15352 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 1.24e-04 | 98 | 70 | 5 | M776 | |
| Pathway | REACTOME_AUTOPHAGY | 1.31e-04 | 158 | 70 | 6 | M27935 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | 1.35e-04 | 307 | 70 | 8 | M894 | |
| Pathway | REACTOME_CELL_CYCLE | TUBB8 SYNE1 TUBB TUBB2B TUBB2A TUBB6 TUBB4A TUBB4B HERC2 CDC25B PCBP4 TP53BP1 | 1.41e-04 | 694 | 70 | 12 | M543 |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 1.72e-04 | 105 | 70 | 5 | MM15206 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 1.83e-04 | 168 | 70 | 6 | MM14785 | |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | 2.04e-04 | 326 | 70 | 8 | M39379 | |
| Pubmed | Mutations in the β-tubulin gene TUBB5 cause microcephaly with structural brain abnormalities. | 1.93e-14 | 8 | 106 | 6 | 23246003 | |
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 3.28e-13 | 22 | 106 | 7 | 16526095 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 3.28e-13 | 22 | 106 | 7 | 23826228 | |
| Pubmed | 1.43e-12 | 6 | 106 | 5 | 24275654 | ||
| Pubmed | 3.63e-11 | 21 | 106 | 6 | 30110642 | ||
| Pubmed | TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology. | 4.98e-11 | 22 | 106 | 6 | 30446499 | |
| Pubmed | 8.15e-11 | 4 | 106 | 4 | 11120798 | ||
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 3.02e-10 | 13 | 106 | 5 | 10908577 | |
| Pubmed | PEX14 is required for microtubule-based peroxisome motility in human cells. | 3.15e-10 | 54 | 106 | 7 | 21525035 | |
| Pubmed | Mitochondria-cytoskeleton interaction: distribution of β-tubulins in cardiomyocytes and HL-1 cells. | 4.07e-10 | 5 | 106 | 4 | 21296049 | |
| Pubmed | 4.68e-10 | 14 | 106 | 5 | 12486001 | ||
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 3782288 | ||
| Pubmed | 2.45e-09 | 40 | 106 | 6 | 30865227 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | MIA3 SETD1B HUWE1 ARID1A LARP4 RPS6KC1 TUBB6 PELP1 SMARCA2 USP54 HERC2 TP53BP1 | 1.09e-08 | 440 | 106 | 12 | 34244565 |
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 6688039 | ||
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 22767497 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SETD1B WASHC2C TUBB2B SMARCAD1 ITPRID2 HUWE1 ARID1A TUBB2A PAPOLG TUBB4A NAV1 SECISBP2 TP53BP1 | 3.06e-08 | 588 | 106 | 13 | 38580884 |
| Pubmed | 3.21e-08 | 30 | 106 | 5 | 25864199 | ||
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 3.96e-08 | 12 | 106 | 4 | 15331610 | |
| Pubmed | EGLN2 SYNE1 TUBB TUBB2B SMARCAD1 HUWE1 ARID1A TUBB2A NFE2L3 TUBB4A TUBB4B WIZ RETREG1 EXOC1 USP54 HERC2 RAPGEF2 CABIN1 | 6.50e-08 | 1285 | 106 | 18 | 35914814 | |
| Pubmed | Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2. | 1.10e-07 | 4 | 106 | 3 | 39142074 | |
| Pubmed | 1.10e-07 | 4 | 106 | 3 | 19545277 | ||
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 1.19e-07 | 125 | 106 | 7 | 36030824 | |
| Pubmed | 1.88e-07 | 17 | 106 | 4 | 17360745 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNC SETD1B HUWE1 ARID1A BTN3A2 RYR1 PRR12 RHPN1 SNX30 CELSR1 WIZ MEGF8 CSAD NAV1 HERC2 CABIN1 | 2.45e-07 | 1105 | 106 | 16 | 35748872 |
| Pubmed | 2.74e-07 | 5 | 106 | 3 | 29339503 | ||
| Pubmed | Five mouse tubulin isotypes and their regulated expression during development. | 2.74e-07 | 5 | 106 | 3 | 3839797 | |
| Pubmed | 3.05e-07 | 19 | 106 | 4 | 15698476 | ||
| Pubmed | 3.05e-07 | 19 | 106 | 4 | 15691386 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FLNC TUBB8 FOS TUBB HIC2 SMARCAD1 HUWE1 PPARG TUBB2A WIZ PELP1 NFKB1 CABIN1 TP53BP1 | 3.56e-07 | 857 | 106 | 14 | 25609649 |
| Pubmed | 3.75e-07 | 148 | 106 | 7 | 35676246 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 5.97e-07 | 232 | 106 | 8 | 25515538 | |
| Pubmed | 6.19e-07 | 99 | 106 | 6 | 29676259 | ||
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 6.58e-07 | 235 | 106 | 8 | 28378594 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNC SETD1B TUBB TUBB2B SMARCAD1 HUWE1 TSSC4 ARID1A LARP4 TUBB6 RIN1 TUBB4B SMARCA2 EXOC1 HERC2 GMPPB TP53BP1 | 7.17e-07 | 1353 | 106 | 17 | 29467282 |
| Pubmed | 8.15e-07 | 166 | 106 | 7 | 34687317 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | WASHC2C TUBB SMARCAD1 HUWE1 TUBB6 TUBB4A TUBB4B PELP1 TP53BP1 | 8.61e-07 | 332 | 106 | 9 | 32786267 |
| Pubmed | The cluster of BTN genes in the extended major histocompatibility complex. | 9.55e-07 | 7 | 106 | 3 | 11170752 | |
| Pubmed | 9.55e-07 | 7 | 106 | 3 | 27010057 | ||
| Pubmed | MIA3 TSPYL1 ARID1A TUBB2A TUBB6 NAV1 PPP1R9B USP54 RAPGEF2 PLEKHA7 | 1.16e-06 | 446 | 106 | 10 | 24255178 | |
| Pubmed | MIA3 SYNE1 TUBB2B HUWE1 TMEM132B TUBB6 WIZ PELP1 NAV1 PPP1R9B HERC2 RAPGEF2 CABIN1 TP53BP1 | 1.41e-06 | 963 | 106 | 14 | 28671696 | |
| Pubmed | 1.81e-06 | 187 | 106 | 7 | 26460568 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MIA3 WASHC2C TUBB8 TUBB2B PLEKHG2 TSFM TUBB6 TUBB4A NFKB1 PHACTR4 USP54 HERC2 PLEKHA7 | 2.07e-06 | 853 | 106 | 13 | 28718761 |
| Pubmed | 2.08e-06 | 191 | 106 | 7 | 20195357 | ||
| Pubmed | Murine fertility and spermatogenesis are independent of the testis-specific Spdye4a gene. | 2.28e-06 | 9 | 106 | 3 | 36272447 | |
| Pubmed | 2.64e-06 | 198 | 106 | 7 | 24337577 | ||
| Pubmed | Postnatal refinement of auditory hair cell planar polarity deficits occurs in the absence of Vangl2. | 3.25e-06 | 10 | 106 | 3 | 23986237 | |
| Pubmed | 3.72e-06 | 76 | 106 | 5 | 27542412 | ||
| Pubmed | 4.14e-06 | 212 | 106 | 7 | 23463506 | ||
| Pubmed | SETD1B WASHC2C ZSWIM5 SYNE1 SMARCAD1 USP19 MEGF8 RHOBTB2 NAV1 | 4.55e-06 | 407 | 106 | 9 | 12693553 | |
| Pubmed | 5.73e-06 | 145 | 106 | 6 | 23349634 | ||
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | 6.64e-06 | 321 | 106 | 8 | 32098917 | |
| Pubmed | Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins. | 7.70e-06 | 13 | 106 | 3 | 15611625 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 20573495 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 30621030 | ||
| Pubmed | Gender differences in food allergy depend on the PPAR γ/NF-κB in the intestines of mice. | 9.20e-06 | 2 | 106 | 2 | 33974930 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 18305042 | ||
| Pubmed | Prolyl hydroxylase-1 regulates hepatocyte apoptosis in an NF-κB-dependent manner. | 9.20e-06 | 2 | 106 | 2 | 27130823 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 8151786 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 8270253 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 11318604 | ||
| Pubmed | Pollen-derived E1-phytoprostanes signal via PPAR-gamma and NF-kappaB-dependent mechanisms. | 9.20e-06 | 2 | 106 | 2 | 19454659 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22484628 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22248180 | ||
| Pubmed | Differential role for CD277 as a co-regulator of the immune signal in T and NK cells. | 9.20e-06 | 2 | 106 | 2 | 21918970 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17627938 | ||
| Pubmed | A minor beta-tubulin essential for mammalian cell proliferation. | 9.20e-06 | 2 | 106 | 2 | 18553364 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22846996 | ||
| Pubmed | Omega-3 fatty acids attenuate dendritic cell function via NF-κB independent of PPARγ. | 9.20e-06 | 2 | 106 | 2 | 21111596 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 27327083 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19829671 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 30219229 | ||
| Pubmed | Multiminicore Disease – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 9.20e-06 | 2 | 106 | 2 | 20301467 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 38320873 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 38031972 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 18713863 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 21113407 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 6865944 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 23199346 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 18425349 | ||
| Pubmed | 1.10e-05 | 45 | 106 | 4 | 30619335 | ||
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 1.11e-05 | 95 | 106 | 5 | 27129302 | |
| Pubmed | 1.50e-05 | 16 | 106 | 3 | 14594945 | ||
| Pubmed | 1.73e-05 | 104 | 106 | 5 | 36055981 | ||
| Pubmed | 1.73e-05 | 104 | 106 | 5 | 9205841 | ||
| Pubmed | 1.81e-05 | 266 | 106 | 7 | 19380743 | ||
| Pubmed | Characterization of a new family of cyclin-dependent kinase activators. | 1.81e-05 | 17 | 106 | 3 | 15574121 | |
| Pubmed | 1.87e-05 | 486 | 106 | 9 | 20936779 | ||
| Pubmed | 1.90e-05 | 106 | 106 | 5 | 19394292 | ||
| Pubmed | A 1.1-Mb transcript map of the hereditary hemochromatosis locus. | 2.17e-05 | 18 | 106 | 3 | 9149941 | |
| Pubmed | 2.17e-05 | 18 | 106 | 3 | 21270055 | ||
| Pubmed | 2.57e-05 | 19 | 106 | 3 | 29435596 | ||
| Pubmed | 2.63e-05 | 282 | 106 | 7 | 23667531 | ||
| Pubmed | Tumoral and tissue-specific expression of the major human beta-tubulin isotypes. | 2.76e-05 | 3 | 106 | 2 | 20191564 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 24594319 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 22983445 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 22763696 | ||
| Pubmed | A ubiquitous beta-tubulin disrupts microtubule assembly and inhibits cell proliferation. | 2.76e-05 | 3 | 106 | 2 | 15121885 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 10646849 | ||
| Pubmed | Aldolase-tubulin interactions: removal of tubulin C-terminals impairs interactions. | 2.76e-05 | 3 | 106 | 2 | 8103323 | |
| Interaction | CAPS interactions | 4.05e-11 | 25 | 106 | 7 | int:CAPS | |
| Interaction | TPSB2 interactions | 3.24e-10 | 18 | 106 | 6 | int:TPSB2 | |
| Interaction | SIRT6 interactions | FAT4 MIA3 SETD1B TUBB8 HUWE1 PPARG ARID1A LARP4 TUBB2A RPS6KC1 TUBB6 CELSR1 WIZ PELP1 SMARCA2 USP54 HERC2 TP53BP1 | 4.52e-09 | 628 | 106 | 18 | int:SIRT6 |
| Interaction | ZC2HC1B interactions | 6.29e-09 | 28 | 106 | 6 | int:ZC2HC1B | |
| Interaction | TMPRSS5 interactions | 1.88e-07 | 48 | 106 | 6 | int:TMPRSS5 | |
| Interaction | TTC5 interactions | 1.18e-06 | 65 | 106 | 6 | int:TTC5 | |
| Interaction | HDAC4 interactions | SETD1B WASHC2C TUBB GATA1 HUWE1 PPARG TUBB2A RPS6KC1 PRR12 NFKB1 NAV1 HERC2 RAPGEF2 CDC25B PLEKHA7 TP53BP1 | 1.69e-06 | 744 | 106 | 16 | int:HDAC4 |
| Interaction | RNF43 interactions | MIA3 TUBB TUBB2B ARID1A LARP4 TUBB2A TUBB6 TUBB4A TUBB4B SECISBP2 USP54 PLEKHA7 | 2.56e-06 | 427 | 106 | 12 | int:RNF43 |
| Interaction | TCP11L1 interactions | 2.75e-06 | 75 | 106 | 6 | int:TCP11L1 | |
| Interaction | LOC254896 interactions | 3.01e-06 | 43 | 106 | 5 | int:LOC254896 | |
| Interaction | EEF1AKMT3 interactions | TUBB8 SMARCAD1 HUWE1 TSPYL1 TUBB2A TUBB6 RIN1 TUBB4A ELMO3 NFKB1 NAV1 | 3.45e-06 | 364 | 106 | 11 | int:EEF1AKMT3 |
| Interaction | ELK1 interactions | 4.37e-06 | 125 | 106 | 7 | int:ELK1 | |
| Interaction | IL12RB1 interactions | 6.56e-06 | 87 | 106 | 6 | int:IL12RB1 | |
| Interaction | PPEF1 interactions | 7.82e-06 | 52 | 106 | 5 | int:PPEF1 | |
| Interaction | DPF1 interactions | 1.09e-05 | 95 | 106 | 6 | int:DPF1 | |
| Interaction | NXPH3 interactions | 1.34e-05 | 58 | 106 | 5 | int:NXPH3 | |
| Interaction | GABRA1 interactions | 1.58e-05 | 152 | 106 | 7 | int:GABRA1 | |
| Interaction | TOP3B interactions | FLNC SETD1B HUWE1 ARID1A LARP4 BTN3A2 RYR1 PRR12 RHPN1 SNX30 CELSR1 WIZ MEGF8 PELP1 CSAD NAV1 SECISBP2 PPP1R9B HERC2 CABIN1 TP53BP1 | 2.26e-05 | 1470 | 106 | 21 | int:TOP3B |
| Interaction | KLK5 interactions | 2.40e-05 | 109 | 106 | 6 | int:KLK5 | |
| Interaction | BAGE2 interactions | 3.38e-05 | 70 | 106 | 5 | int:BAGE2 | |
| Interaction | PEX14 interactions | 3.64e-05 | 237 | 106 | 8 | int:PEX14 | |
| Interaction | B4GALT2 interactions | 3.94e-05 | 119 | 106 | 6 | int:B4GALT2 | |
| Interaction | TUBA1C interactions | PDE3A TUBB8 TUBB TUBB2B HUWE1 TUBB2A TUBB6 TUBB4A TUBB4B PPP1R9B HERC2 | 4.36e-05 | 478 | 106 | 11 | int:TUBA1C |
| Interaction | TUBB2A interactions | 4.43e-05 | 316 | 106 | 9 | int:TUBB2A | |
| Interaction | EML2 interactions | 4.65e-05 | 38 | 106 | 4 | int:EML2 | |
| Interaction | CAPSL interactions | 6.15e-05 | 15 | 106 | 3 | int:CAPSL | |
| Interaction | ATOH1 interactions | 6.43e-05 | 80 | 106 | 5 | int:ATOH1 | |
| Interaction | OSTM1 interactions | 6.43e-05 | 80 | 106 | 5 | int:OSTM1 | |
| Interaction | ARL2 interactions | 7.03e-05 | 132 | 106 | 6 | int:ARL2 | |
| Interaction | FAM86B2 interactions | 7.54e-05 | 16 | 106 | 3 | int:FAM86B2 | |
| Interaction | GLMP interactions | 8.13e-05 | 84 | 106 | 5 | int:GLMP | |
| Interaction | HEY1 interactions | 9.74e-05 | 140 | 106 | 6 | int:HEY1 | |
| Interaction | TBCD interactions | 1.01e-04 | 141 | 106 | 6 | int:TBCD | |
| Interaction | MAPK7 interactions | 1.09e-04 | 143 | 106 | 6 | int:MAPK7 | |
| Interaction | NFIC interactions | 1.23e-04 | 210 | 106 | 7 | int:NFIC | |
| Interaction | RBBP5 interactions | 1.39e-04 | 287 | 106 | 8 | int:RBBP5 | |
| Interaction | SS18L1 interactions | 1.69e-04 | 98 | 106 | 5 | int:SS18L1 | |
| Interaction | CCT2 interactions | TUBB8 TUBB TUBB2B HUWE1 TUBB2A TUBB6 TUBB4A TUBB4B RHOBTB2 PPP1R9B USP54 ENDOV | 1.98e-04 | 666 | 106 | 12 | int:CCT2 |
| Interaction | CDC42SE2 interactions | 2.03e-04 | 22 | 106 | 3 | int:CDC42SE2 | |
| Interaction | RUVBL1 interactions | TUBB SMARCAD1 HUWE1 PPARG TSSC4 ARID1A TUBB2A TUBB4B PELP1 SMARCA2 TP53BP1 | 2.23e-04 | 575 | 106 | 11 | int:RUVBL1 |
| Interaction | CCT7 interactions | FLNC TUBB8 TUBB TUBB2B HUWE1 TUBB2A TUBB6 TUBB4A TUBB4B RHOBTB2 PPP1R9B | 2.23e-04 | 575 | 106 | 11 | int:CCT7 |
| Interaction | RPGR interactions | 2.30e-04 | 57 | 106 | 4 | int:RPGR | |
| Interaction | BTN3A1 interactions | 2.32e-04 | 23 | 106 | 3 | int:BTN3A1 | |
| Interaction | NPHP4 interactions | 2.52e-04 | 236 | 106 | 7 | int:NPHP4 | |
| Interaction | DYNC1H1 interactions | PRUNE2 FLNC TUBB HUWE1 TUBB2A TUBB4A TUBB4B NFKB1 PPP1R9B PCBP4 | 2.65e-04 | 491 | 106 | 10 | int:DYNC1H1 |
| Interaction | EDN3 interactions | 2.66e-04 | 108 | 106 | 5 | int:EDN3 | |
| Interaction | ASB17 interactions | 2.99e-04 | 25 | 106 | 3 | int:ASB17 | |
| Interaction | PPM1D interactions | 3.00e-04 | 61 | 106 | 4 | int:PPM1D | |
| Interaction | CREBBP interactions | FOS TUBB GATA1 HUWE1 PPARG ARID1A MKNK1 PELP1 SMARCA2 CDC25B TP53BP1 | 3.16e-04 | 599 | 106 | 11 | int:CREBBP |
| Interaction | METTL22 interactions | 3.37e-04 | 26 | 106 | 3 | int:METTL22 | |
| Interaction | BTN3A3 interactions | 3.37e-04 | 26 | 106 | 3 | int:BTN3A3 | |
| Interaction | BTN3A2 interactions | 3.37e-04 | 26 | 106 | 3 | int:BTN3A2 | |
| Interaction | ARID1B interactions | 3.48e-04 | 177 | 106 | 6 | int:ARID1B | |
| Interaction | TES interactions | 3.71e-04 | 332 | 106 | 8 | int:TES | |
| Interaction | GAN interactions | 3.83e-04 | 253 | 106 | 7 | int:GAN | |
| Interaction | EML3 interactions | 4.06e-04 | 66 | 106 | 4 | int:EML3 | |
| Interaction | ETS1 interactions | 4.49e-04 | 121 | 106 | 5 | int:ETS1 | |
| Interaction | CDHR4 interactions | 4.55e-04 | 68 | 106 | 4 | int:CDHR4 | |
| Interaction | BCL7A interactions | 4.84e-04 | 123 | 106 | 5 | int:BCL7A | |
| Interaction | HNF1B interactions | 5.07e-04 | 190 | 106 | 6 | int:HNF1B | |
| Interaction | DPF2 interactions | 5.16e-04 | 349 | 106 | 8 | int:DPF2 | |
| Interaction | METTL23 interactions | 5.18e-04 | 30 | 106 | 3 | int:METTL23 | |
| Interaction | CDC42 interactions | FLNC FAT4 PDE3A ZSWIM5 SYNE1 TUBB PLEKHG2 HUWE1 BTN3A2 TSFM PLEKHG4B TUBB4A TUBB4B PHACTR4 PPP1R9B HERC2 PLEKHA7 | 5.25e-04 | 1323 | 106 | 17 | int:CDC42 |
| Cytoband | 19q13.2 | 5.87e-04 | 164 | 106 | 4 | 19q13.2 | |
| Cytoband | 6p25 | 6.20e-04 | 16 | 106 | 2 | 6p25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p25 | 1.29e-03 | 92 | 106 | 3 | chr6p25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.80e-03 | 1192 | 106 | 9 | chr19q13 | |
| Cytoband | 7q22.1 | 2.33e-03 | 113 | 106 | 3 | 7q22.1 | |
| Cytoband | 1p35.3 | 2.82e-03 | 34 | 106 | 2 | 1p35.3 | |
| GeneFamily | Tubulins | 1.08e-11 | 26 | 76 | 7 | 778 | |
| GeneFamily | Speedy/RINGO cell cycle regulator family | 1.53e-05 | 12 | 76 | 3 | 756 | |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 3.13e-05 | 15 | 76 | 3 | 458 | |
| GeneFamily | PDZ domain containing | 4.49e-04 | 152 | 76 | 5 | 1220 | |
| GeneFamily | ATP binding cassette subfamily A | 1.54e-03 | 14 | 76 | 2 | 805 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.86e-07 | 200 | 105 | 7 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 4.86e-07 | 200 | 105 | 7 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Interneuron|1m / Sample Type, Dataset, Time_group, and Cell type. | 4.86e-07 | 200 | 105 | 7 | fc839e9c33ea1d4ee0f42f21fd32a54e7cbe1f5a | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.61e-06 | 188 | 105 | 6 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | droplet-Fat-SCAT-30m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-06 | 189 | 105 | 6 | 8161910a19089f8cc5a3f1fda039f41a2488f04f | |
| ToppCell | droplet-Fat-SCAT|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.78e-06 | 189 | 105 | 6 | 264c59de2adb8bee5bb57633d79d530a8829617b | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 7.12e-06 | 196 | 105 | 6 | af00c31612e4fe068e5fccae05368edba46bbd20 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.33e-06 | 197 | 105 | 6 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.77e-06 | 199 | 105 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 7.77e-06 | 199 | 105 | 6 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 7.99e-06 | 200 | 105 | 6 | 332905a686356cd1e024d40679be98e9d8b1b5e8 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-05 | 147 | 105 | 5 | 989a48bda98fbff398985397a6b1189a4cbc80e7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-05 | 147 | 105 | 5 | f6681c849c4c06154548bd29a094f202d1c946c2 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.36e-05 | 164 | 105 | 5 | 3d8ff70fe5582d1fb56b338be8b76fa1428b3657 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.02e-05 | 169 | 105 | 5 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.02e-05 | 169 | 105 | 5 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 5.31e-05 | 171 | 105 | 5 | f3bf5805823d5733b58742172e7668725ce82931 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.61e-05 | 173 | 105 | 5 | 20f7dfe7d92a3dbec9da9a1f3185aa10cb8f0a3c | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue-3|TCGA-Breast / Sample_Type by Project: Shred V9 | 5.77e-05 | 174 | 105 | 5 | 7f8f5fafae08676d2b90cab9802c3c9320f1370e | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal|TCGA-Breast / Sample_Type by Project: Shred V9 | 5.77e-05 | 174 | 105 | 5 | e2f240d60bffbe8e6d60f0bb405b231bd3c96875 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 5.77e-05 | 174 | 105 | 5 | 0f3ec0d0d4344e10c9b48adc9174123f6402dc51 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.77e-05 | 174 | 105 | 5 | e5f12831187140e84b9a49e93b2376b9fefb1aec | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 5.77e-05 | 174 | 105 | 5 | 1aadbf2642b6d1320ceabd92e6ff59e11f16c315 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.93e-05 | 175 | 105 | 5 | 6374ab186d7ccf7f6dfb858267edba8962789e15 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 175 | 105 | 5 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.09e-05 | 176 | 105 | 5 | 33323c97afe509147956b8df9f92ca6b0537e604 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.09e-05 | 176 | 105 | 5 | bd5c85b3a4fb88ffe156599f6d224aa7664a513a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.26e-05 | 177 | 105 | 5 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.26e-05 | 177 | 105 | 5 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 6.26e-05 | 177 | 105 | 5 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.26e-05 | 177 | 105 | 5 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.26e-05 | 177 | 105 | 5 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Activated_fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.60e-05 | 179 | 105 | 5 | 5787ffba96918db80256ced076a455a84ba01384 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.60e-05 | 179 | 105 | 5 | 6718cadcc2d3b64717ed84244ef1242d392662dc | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.32e-05 | 183 | 105 | 5 | 983ca1342ddd365e1f1df32a456394b002b10e41 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.51e-05 | 184 | 105 | 5 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 7.71e-05 | 185 | 105 | 5 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.71e-05 | 185 | 105 | 5 | 6aeae77a087d695b1e58c5f63265e7113aa2e343 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.91e-05 | 186 | 105 | 5 | 55b239834b96b1f7787ec77a7d19796d617bbbf0 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.91e-05 | 186 | 105 | 5 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.91e-05 | 186 | 105 | 5 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.91e-05 | 186 | 105 | 5 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.11e-05 | 187 | 105 | 5 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.11e-05 | 187 | 105 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 8.11e-05 | 187 | 105 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.32e-05 | 188 | 105 | 5 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-05 | 188 | 105 | 5 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.53e-05 | 189 | 105 | 5 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.53e-05 | 189 | 105 | 5 | 28b502611829e4a24caff2562545c7db97686099 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.74e-05 | 190 | 105 | 5 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-05 | 191 | 105 | 5 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-05 | 191 | 105 | 5 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 191 | 105 | 5 | 3387b95a3f2445c672d407922fdce3a91eabaef8 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 8.96e-05 | 191 | 105 | 5 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.96e-05 | 191 | 105 | 5 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.18e-05 | 192 | 105 | 5 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.18e-05 | 192 | 105 | 5 | fe9297cb65234d9f511bab1a5dbf2679d5a4cd15 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 9.18e-05 | 192 | 105 | 5 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Endothelial|World / shred on cell class and cell subclass (v4) | 9.18e-05 | 192 | 105 | 5 | 2b13cca5c4b58628dbbbb356859632dba66d43f9 | |
| ToppCell | Control|World / Disease condition and Cell class | 9.41e-05 | 193 | 105 | 5 | 92347e919c8425f33692e121df6ca5d841748f6c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.41e-05 | 193 | 105 | 5 | a189d46c39067b717509cd144e0225cc93d7731d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.41e-05 | 193 | 105 | 5 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_mature_DC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.41e-05 | 193 | 105 | 5 | d9be4d1de863fffc2240d6fd1a2f8dfb2d2bc916 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.41e-05 | 193 | 105 | 5 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | ILEUM-inflamed-(3)_mature_DC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.64e-05 | 194 | 105 | 5 | 369bbf4e8e2d674e5a51a614b52b97d05d3ab9c7 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.64e-05 | 194 | 105 | 5 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.64e-05 | 194 | 105 | 5 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.64e-05 | 194 | 105 | 5 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.87e-05 | 195 | 105 | 5 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 9.87e-05 | 195 | 105 | 5 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 196 | 105 | 5 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.01e-04 | 196 | 105 | 5 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-04 | 196 | 105 | 5 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | wk_08-11-Epithelial-PNS-TM4SF4+_PENK+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.01e-04 | 196 | 105 | 5 | afa3a2f5f3a51d1830c6f95f97a4b3e13ed42512 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.01e-04 | 196 | 105 | 5 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.01e-04 | 196 | 105 | 5 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-04 | 196 | 105 | 5 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.04e-04 | 197 | 105 | 5 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD8-Tem/emra_CD8|Lung / Manually curated celltypes from each tissue | 1.04e-04 | 197 | 105 | 5 | a573a59e2271f5d0ce5de0b851951ab72659e060 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD8|Lung / Manually curated celltypes from each tissue | 1.04e-04 | 197 | 105 | 5 | b2f5b35e931c1342e541ecf05933350c41612415 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-04 | 197 | 105 | 5 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 197 | 105 | 5 | 27c044833e471a312a572e0b1c83e4bc8a36e896 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 197 | 105 | 5 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.04e-04 | 197 | 105 | 5 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | wk_08-11-Epithelial-PNS|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.04e-04 | 197 | 105 | 5 | ce3f9feb6935f0e9daf13673b0a0d6e92817e187 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 197 | 105 | 5 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-04 | 197 | 105 | 5 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | T_cells-CTLs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.04e-04 | 197 | 105 | 5 | 2de34e20915a247bee75aa40495e23c20bb23e18 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.04e-04 | 197 | 105 | 5 | d4dfb3b561d0783cdbee4e8d27009ad81df695cb | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.06e-04 | 198 | 105 | 5 | b73b9feb82997b654718aa27f33ca7b454214802 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 198 | 105 | 5 | 7b9c7ce5d6b7df8db85943b65da1a2c202a8bb53 | |
| ToppCell | wk_08-11-Epithelial-PNS-TM4SF4+_CHODL+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.06e-04 | 198 | 105 | 5 | eb3c389e7452d74e5e15179503e480d6d11ca9ca | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 198 | 105 | 5 | 800ade4261695f2efd869d2b1243571de963c431 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-04 | 199 | 105 | 5 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-04 | 199 | 105 | 5 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.09e-04 | 199 | 105 | 5 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 199 | 105 | 5 | f2410509007d35e948a88f127f613d0119e6a4c4 | |
| Drug | 2,3,4-tabp | 8.36e-12 | 23 | 105 | 7 | CID000125548 | |
| Drug | NSC355636 | 8.36e-12 | 23 | 105 | 7 | CID000100176 | |
| Drug | IKP104 | 8.36e-12 | 23 | 105 | 7 | CID000130739 | |
| Drug | 2,3,4-TCB | 8.36e-12 | 23 | 105 | 7 | CID000129239 | |
| Drug | N-acetylcolchinol | 8.36e-12 | 23 | 105 | 7 | CID000097865 | |
| Drug | parbendazole | 1.18e-11 | 24 | 105 | 7 | CID000026596 | |
| Drug | tropolone methyl ether | 1.18e-11 | 24 | 105 | 7 | CID000016546 | |
| Drug | AC1L4TG7 | 1.18e-11 | 24 | 105 | 7 | CID000163705 | |
| Drug | NSC-36768 | 1.18e-11 | 24 | 105 | 7 | CID000165441 | |
| Drug | deacetamidocolchicine | 1.18e-11 | 24 | 105 | 7 | CID000014995 | |
| Drug | colchicide | 1.18e-11 | 24 | 105 | 7 | CID000120712 | |
| Drug | AC1Q6P06 | 1.63e-11 | 25 | 105 | 7 | CID000160263 | |
| Drug | allocolchicine | 1.63e-11 | 25 | 105 | 7 | CID000196989 | |
| Drug | 55623-37-5 | 1.63e-11 | 25 | 105 | 7 | CID006438440 | |
| Drug | MDL 27048 | 1.63e-11 | 25 | 105 | 7 | CID006439188 | |
| Drug | NBD-colcemid | 1.63e-11 | 25 | 105 | 7 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 1.63e-11 | 25 | 105 | 7 | CID000043264 | |
| Drug | NSC527981 | 2.22e-11 | 26 | 105 | 7 | CID000352796 | |
| Drug | NSC332029 | 2.22e-11 | 26 | 105 | 7 | CID000100073 | |
| Drug | pironetin | 2.22e-11 | 26 | 105 | 7 | CID006438891 | |
| Drug | AC1L1J4H | 2.98e-11 | 27 | 105 | 7 | CID000004862 | |
| Drug | dinitroanilines | 2.98e-11 | 27 | 105 | 7 | CID000136400 | |
| Drug | NSC292222 | 2.98e-11 | 27 | 105 | 7 | CID000099957 | |
| Drug | NSC D-669356 | 2.98e-11 | 27 | 105 | 7 | CID000178028 | |
| Drug | NSC 370147 | 3.96e-11 | 28 | 105 | 7 | CID000182762 | |
| Drug | NSC72302 | 3.96e-11 | 28 | 105 | 7 | CID000118078 | |
| Drug | oxibendazole | 5.20e-11 | 29 | 105 | 7 | CID000004622 | |
| Drug | AC1NBBHE | 6.76e-11 | 30 | 105 | 7 | CID004490620 | |
| Drug | eleutherobin | 6.76e-11 | 30 | 105 | 7 | CID006918335 | |
| Drug | azatoxin | 6.76e-11 | 30 | 105 | 7 | CID000125383 | |
| Drug | NSC617668 | 6.76e-11 | 30 | 105 | 7 | CID000357989 | |
| Drug | citostal | 6.76e-11 | 30 | 105 | 7 | CID000018991 | |
| Drug | thiocolchicine | 6.76e-11 | 30 | 105 | 7 | CID000017648 | |
| Drug | Z)-combretastatin A-4 | 7.14e-11 | 50 | 105 | 8 | CID000072686 | |
| Drug | NSC609395 | 8.70e-11 | 31 | 105 | 7 | CID005488798 | |
| Drug | amiprophosmethyl | 8.70e-11 | 31 | 105 | 7 | CID000100524 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 8.70e-11 | 31 | 105 | 7 | CID000032851 | |
| Drug | tropone | 8.70e-11 | 31 | 105 | 7 | CID000010881 | |
| Drug | AC1L3V8I | 8.70e-11 | 31 | 105 | 7 | CID000122777 | |
| Drug | NSC332598 | 8.70e-11 | 31 | 105 | 7 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 8.70e-11 | 31 | 105 | 7 | CID000023678 | |
| Drug | AC1L1G95 | 1.11e-10 | 32 | 105 | 7 | CID000003583 | |
| Drug | NSC153858 | 1.11e-10 | 32 | 105 | 7 | CID000547450 | |
| Drug | 2-demethylcolchicine | 1.11e-10 | 32 | 105 | 7 | CID000023757 | |
| Drug | procaine | TUBB8 FOS TUBB TUBB2B TUBB2A RYR1 PRKD3 TUBB6 TUBB4A TUBB4B SCN4A | 1.27e-10 | 153 | 105 | 11 | CID000004914 |
| Drug | mebendazole | 1.40e-10 | 33 | 105 | 7 | CID000004030 | |
| Drug | CA4P | 1.40e-10 | 33 | 105 | 7 | CID000370232 | |
| Drug | taltobulin | 1.40e-10 | 33 | 105 | 7 | CID006918637 | |
| Drug | NSC376450 | 1.76e-10 | 34 | 105 | 7 | CID000005605 | |
| Drug | 2-phenyl-4-quinolone | 1.76e-10 | 34 | 105 | 7 | CID000161091 | |
| Drug | discodermolide | 2.19e-10 | 35 | 105 | 7 | CID000643668 | |
| Drug | AC1O5Y0F | 3.33e-10 | 37 | 105 | 7 | CID006442852 | |
| Drug | DTAF | 3.33e-10 | 37 | 105 | 7 | CID000123934 | |
| Drug | albendazole | 3.33e-10 | 37 | 105 | 7 | CID000002082 | |
| Drug | baccatin III | 3.33e-10 | 37 | 105 | 7 | CID000065366 | |
| Drug | gnoscopine | 4.06e-10 | 38 | 105 | 7 | CID000004544 | |
| Drug | laulimalide | 4.06e-10 | 38 | 105 | 7 | CID006918457 | |
| Drug | colchiceine | 4.06e-10 | 38 | 105 | 7 | CID000010156 | |
| Drug | bromocolchicine | 4.27e-10 | 21 | 105 | 6 | CID000161518 | |
| Drug | colchifoline | 4.27e-10 | 21 | 105 | 6 | CID000100132 | |
| Drug | Ustiloxin A | 4.27e-10 | 21 | 105 | 6 | CID000164454 | |
| Drug | SRI-3072 | 4.27e-10 | 21 | 105 | 6 | CID000493469 | |
| Drug | benzimidazole | 4.64e-10 | 93 | 105 | 9 | CID000005798 | |
| Drug | erianin | 4.94e-10 | 39 | 105 | 7 | CID000356759 | |
| Drug | Dolastatin 10 | 4.94e-10 | 39 | 105 | 7 | CID000100208 | |
| Drug | 3,4,5-trimethoxyacetophenone | 5.85e-10 | 22 | 105 | 6 | CID000014345 | |
| Drug | AC1L1GIQ | 5.85e-10 | 22 | 105 | 6 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 5.85e-10 | 22 | 105 | 6 | CID000098538 | |
| Drug | SureCN13401588 | 5.85e-10 | 22 | 105 | 6 | CID009897422 | |
| Drug | N-methyldemecolcine | 5.85e-10 | 22 | 105 | 6 | CID000023759 | |
| Drug | NSC-339672 | 5.85e-10 | 22 | 105 | 6 | CID000433930 | |
| Drug | AC1L8GZ1 | 5.96e-10 | 40 | 105 | 7 | CID000381235 | |
| Drug | lumicolchicine | 7.16e-10 | 41 | 105 | 7 | CID000072624 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 7.89e-10 | 23 | 105 | 6 | CID000006858 | |
| Drug | AC1L2P05 | 7.89e-10 | 23 | 105 | 6 | CID000125688 | |
| Drug | NSC-373301 | 7.89e-10 | 23 | 105 | 6 | CID000341375 | |
| Drug | fluorescein-colchicine | 7.89e-10 | 23 | 105 | 6 | CID003035871 | |
| Drug | 3-demethylthiocolchicine | 7.89e-10 | 23 | 105 | 6 | CID000084076 | |
| Drug | AC1L9CY0 | 1.02e-09 | 43 | 105 | 7 | CID000396644 | |
| Drug | Stylophorin | 1.02e-09 | 43 | 105 | 7 | CID000010147 | |
| Drug | 7-epi-cephalomannine | 1.05e-09 | 24 | 105 | 6 | CID000330401 | |
| Drug | NABV | 1.05e-09 | 24 | 105 | 6 | CID000175959 | |
| Drug | moscatilin | 1.05e-09 | 24 | 105 | 6 | CID000176096 | |
| Drug | mpMap | 1.37e-09 | 25 | 105 | 6 | CID000100806 | |
| Drug | 1069C85 | 1.37e-09 | 25 | 105 | 6 | CID006918099 | |
| Drug | CA1P | 1.37e-09 | 25 | 105 | 6 | CID006918545 | |
| Drug | peloruside A | 1.37e-09 | 25 | 105 | 6 | CID006918506 | |
| Drug | NSC142227 | 1.37e-09 | 25 | 105 | 6 | CID000073427 | |
| Drug | methyl ether | 1.42e-09 | 45 | 105 | 7 | CID000008254 | |
| Drug | indibulin | 1.78e-09 | 26 | 105 | 6 | CID000002929 | |
| Drug | isaxonine | 1.78e-09 | 26 | 105 | 6 | CID000071169 | |
| Drug | NSC654663 | 2.65e-09 | 49 | 105 | 7 | CID000375252 | |
| Drug | GaCl3 | 3.07e-09 | 50 | 105 | 7 | CID000026010 | |
| Drug | combretastatin | 3.55e-09 | 51 | 105 | 7 | CID000100154 | |
| Drug | bp U | 3.63e-09 | 29 | 105 | 6 | CID000368697 | |
| Drug | Aids106696 | 3.63e-09 | 29 | 105 | 6 | CID006475933 | |
| Drug | ddGDP | 3.63e-09 | 29 | 105 | 6 | CID000134739 | |
| Drug | bis-ANS | 3.80e-09 | 81 | 105 | 8 | CID000123808 | |
| Drug | magnesium sulfate | 4.09e-09 | 52 | 105 | 7 | CID000024083 | |
| Drug | vinflunine | 4.09e-09 | 52 | 105 | 7 | CID000157688 | |
| Disease | ptosis (implicated_via_orthology) | 5.30e-16 | 10 | 101 | 7 | DOID:0060260 (implicated_via_orthology) | |
| Disease | tubulinopathy (implicated_via_orthology) | 5.30e-16 | 10 | 101 | 7 | DOID:0112227 (implicated_via_orthology) | |
| Disease | facial paralysis (implicated_via_orthology) | 5.30e-16 | 10 | 101 | 7 | DOID:13934 (implicated_via_orthology) | |
| Disease | complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology) | 5.30e-16 | 10 | 101 | 7 | DOID:0090132 (implicated_via_orthology) | |
| Disease | cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology) | 3.48e-15 | 12 | 101 | 7 | DOID:0050997 (implicated_via_orthology) | |
| Disease | hypokalemic periodic paralysis (implicated_via_orthology) | 8.96e-09 | 8 | 101 | 4 | DOID:14452 (implicated_via_orthology) | |
| Disease | Congenital muscular dystrophy | 8.37e-06 | 12 | 101 | 3 | cv:C0699743 | |
| Disease | Congenital myopathy (disorder) | 8.37e-06 | 12 | 101 | 3 | C0270960 | |
| Disease | Multiminicore myopathy | 1.16e-05 | 2 | 101 | 2 | cv:C0270962 | |
| Disease | Lipoatrophic Diabetes Mellitus | 6.93e-05 | 4 | 101 | 2 | C0011859 | |
| Disease | Rare disease with malignant hyperthermia | 6.93e-05 | 4 | 101 | 2 | cv:C5681128 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 1.15e-04 | 5 | 101 | 2 | C3281201 | |
| Disease | Congenital myopathy with fiber type disproportion | 1.72e-04 | 6 | 101 | 2 | cv:C0546264 | |
| Disease | Familial generalized lipodystrophy | 1.72e-04 | 6 | 101 | 2 | C0221032 | |
| Disease | Malignant neoplasm of breast | ABCA3 ZSWIM5 FOS SYNE1 ARID1A BTN3A2 OTOGL USP54 HERC2 MAGEC2 ZNF541 TP53BP1 | 3.08e-04 | 1074 | 101 | 12 | C0006142 |
| Disease | HDL cholesterol change measurement, response to simvastatin, response to fenofibrate | 3.20e-04 | 8 | 101 | 2 | EFO_0007805, GO_1901557, GO_1903491 | |
| Disease | Colorectal Neoplasms | 3.90e-04 | 277 | 101 | 6 | C0009404 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 4.11e-04 | 9 | 101 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | cervical carcinoma | 4.15e-04 | 182 | 101 | 5 | EFO_0001061 | |
| Disease | plasma trimethylamine N-oxide measurement | 5.13e-04 | 10 | 101 | 2 | EFO_0005691 | |
| Disease | glomerulosclerosis (implicated_via_orthology) | 6.25e-04 | 11 | 101 | 2 | DOID:0050851 (implicated_via_orthology) | |
| Disease | Carcinoma, Granular Cell | 6.90e-04 | 116 | 101 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 6.90e-04 | 116 | 101 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 6.90e-04 | 116 | 101 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 6.90e-04 | 116 | 101 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 6.90e-04 | 116 | 101 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 6.90e-04 | 116 | 101 | 4 | C0001418 | |
| Disease | abdominal adipose tissue measurement | 8.05e-04 | 53 | 101 | 3 | EFO_0803316 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 8.83e-04 | 13 | 101 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 8.83e-04 | 13 | 101 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 8.83e-04 | 13 | 101 | 2 | C0410203 | |
| Disease | Coffin-Siris syndrome | 8.83e-04 | 13 | 101 | 2 | C0265338 | |
| Disease | Myopathy, Centronuclear, 1 | 8.83e-04 | 13 | 101 | 2 | C4551952 | |
| Disease | Congenital Structural Myopathy | 8.83e-04 | 13 | 101 | 2 | C0752282 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.02e-03 | 222 | 101 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 1.03e-03 | 14 | 101 | 2 | C1834558 | |
| Disease | superior frontal gyrus grey matter volume measurement | 1.03e-03 | 14 | 101 | 2 | EFO_0006516 | |
| Disease | Tubular Aggregate Myopathy | 1.03e-03 | 14 | 101 | 2 | C0410207 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.08e-03 | 225 | 101 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | liver volume | 1.18e-03 | 15 | 101 | 2 | EFO_0600048 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 1.18e-03 | 15 | 101 | 2 | C3645536 | |
| Disease | T-Cell Lymphoma | 1.35e-03 | 16 | 101 | 2 | C0079772 | |
| Disease | alcoholic hepatitis (biomarker_via_orthology) | 1.71e-03 | 18 | 101 | 2 | DOID:12351 (biomarker_via_orthology) | |
| Disease | Congenital Fiber Type Disproportion | 1.71e-03 | 18 | 101 | 2 | C0546264 | |
| Disease | Breast Carcinoma | 2.54e-03 | 538 | 101 | 7 | C0678222 | |
| Disease | Nasopharyngeal carcinoma | 2.56e-03 | 22 | 101 | 2 | C2931822 | |
| Disease | female reproductive system disease | 2.80e-03 | 23 | 101 | 2 | EFO_0009549 | |
| Disease | Colorectal Carcinoma | 2.86e-03 | 702 | 101 | 8 | C0009402 | |
| Disease | Myasthenic Syndromes, Congenital | 3.05e-03 | 24 | 101 | 2 | C0751882 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PSGPILAMVGEDADL | 36 | O00478 | |
| PSGPILAMVGEDADL | 36 | O00481 | |
| VVLLDEPSTGMDPEG | 1441 | Q8IUA7 | |
| DEGTPFQMDPETGLI | 291 | Q6V0I7 | |
| PGGPGSLSRMELDES | 41 | O96018 | |
| GEPAVIFLDEPSTGM | 1531 | Q99758 | |
| SLSPEGERAFDGMEP | 21 | Q96MT4 | |
| DGPDMLRTDLGESTA | 2746 | Q9NYQ6 | |
| MEEELPLFSGDSGKP | 1 | O95199 | |
| LEDPGMDSREAGLTP | 801 | Q7Z6P3 | |
| DPLPIGEDGLMDSSR | 241 | Q5JSJ4 | |
| DLSGSIDDLPMGTEG | 641 | O14497 | |
| IDDLPMGTEGALSPG | 646 | O14497 | |
| MSGSDGGLEEEPELS | 1 | P57723 | |
| TVGLTDEGSDDEGMP | 211 | Q9UBF1 | |
| IPDDLGFPEEMSVAS | 206 | P01100 | |
| PGELESTREAAAMGP | 696 | Q96S38 | |
| MFDLEGSLDETGLGP | 4366 | O95714 | |
| SMSHEEEPLGTAGPL | 76 | Q9Y5P6 | |
| GLLEMSELPGDSSVP | 6 | Q96D98 | |
| VGMAPLSVGSLDDEP | 261 | P43897 | |
| GDEEASLGLPISPFM | 976 | Q14432 | |
| SLGDIPLPGSISDGM | 281 | Q9Y4A8 | |
| GLGLGDETDEMPSTE | 11 | Q14315 | |
| PLETDSMDPFGLVTG | 191 | O95750 | |
| GPITLEPTEDGMAGV | 2766 | Q7Z7M0 | |
| PSSLGTDTDIPMDID | 331 | O94806 | |
| DDDAVPPGMESLISA | 281 | P30305 | |
| MGIAESTPDELPSDA | 1 | A6NIK2 | |
| GPGVEMLLSSEDGDA | 291 | Q8IZL8 | |
| GIGLDGDTLAPMETD | 1011 | Q7Z6Z7 | |
| EMGFEIPPGESSESV | 1091 | P28290 | |
| PTTEPGMVLDSVEAG | 11 | Q8IZ21 | |
| GMVLDSVEAGDTTPP | 16 | Q8IZ21 | |
| LSPGEDPELGLEMTA | 191 | Q96IR7 | |
| DAIGGESMPIPTIDT | 686 | Q9BWT3 | |
| MEFPGLGSLGTSEPL | 1 | P15976 | |
| LPNIPGEEDDSSGML | 786 | Q6WRI0 | |
| PSMASLGPEGEELAR | 2006 | Q9Y6J0 | |
| GDMEEGASPPTLESL | 576 | Q96BJ8 | |
| PSGPILAMVGEDADL | 36 | P78410 | |
| MADSEALPSLAGDPV | 1 | Q9Y600 | |
| EESTDGMILGPEDLS | 86 | Q71RC2 | |
| AGTEPDGLDPMVTLS | 151 | Q8NDX9 | |
| TGDDGSQLDSPMEIP | 816 | P32019 | |
| PGTMAEAEDLDGGTL | 546 | Q9NV70 | |
| MALEAAGGPPEETLS | 1 | Q8N8Q3 | |
| ASAGLMEEALPSAPE | 161 | Q96KS0 | |
| TSAAVTEEMPPLEGD | 396 | Q58FG1 | |
| LSPLPMAESTRDGLG | 441 | Q8NBF1 | |
| VTELLAGMPDPTSDE | 4376 | P21817 | |
| RDDFLSPSGMIEGTP | 626 | Q3ZCN5 | |
| LAPGPTMDELSSSEL | 1791 | P56715 | |
| IEMGSSEPLPIADGD | 11 | Q9BUB5 | |
| GPSLADTDLSPMDGI | 1396 | Q8NEY1 | |
| SELGGTPDEPMDLEG | 296 | Q96JB3 | |
| PGGVSLEGSELMFPD | 126 | Q13671 | |
| GMDIPFEEGVLSPSA | 2766 | Q8WUY3 | |
| HMGLADGPPSSLELD | 896 | P35499 | |
| ALGPDGEPIDESSQM | 576 | P51531 | |
| EGDEGSMPADIATLL | 1006 | Q9H4L7 | |
| LSMLQDGAAPTPGEE | 5276 | Q8NF91 | |
| EPEEEIPALLGGTTM | 201 | Q14DG7 | |
| GPVTTEDTPMDAIDA | 1111 | Q5JRA6 | |
| GMGTNDEDELSLGLP | 356 | Q9H6L5 | |
| MGETLGDSPIDPESD | 1 | P37231 | |
| DLSMEALSPAGPLGD | 41 | Q96SF7 | |
| FLMDLSEGELGGPSE | 296 | Q9BYZ6 | |
| SPAEEDALFMDLPTG | 366 | Q6IQ23 | |
| AELSGPEGMDELIST | 576 | Q96T21 | |
| VDLEPGTMDSVRSGP | 66 | Q13885 | |
| EPGLSQEGAMLLSPE | 1271 | Q9UPS6 | |
| PLGLDTLLDGDPAMA | 681 | O95785 | |
| EESLDPPGAMQELLG | 871 | Q9ULL5 | |
| MALCDGSPATEGELP | 361 | Q8TCX5 | |
| DDEMLGPSAPGVDPS | 46 | A6NHP3 | |
| SSEPEEMADLLPGSG | 581 | Q6PIS1 | |
| MAGPTEAETGLAEPR | 1 | Q6UXD7 | |
| TESEAGDMDLSGLPE | 66 | Q9Y4G8 | |
| SEMLASGPIEVGSLP | 946 | O94966 | |
| MADGGEREELLSPSP | 1 | Q9P217 | |
| LQGPEEMLPLSSEGS | 16 | Q5VV52 | |
| EAVGGDSTPSPDLLM | 31 | Q5VWJ9 | |
| VDLEPGTMDSVRSGP | 66 | Q9BUF5 | |
| VDLEPGTMDSVRSGP | 66 | Q3ZCM7 | |
| VDLEPGTMDSVRSGP | 66 | P04350 | |
| MAEPGEGGSETVALP | 46 | Q9H0U9 | |
| NPMPLGSSEEALGDL | 6 | Q96PX9 | |
| DDEMLGPSAPGVDPS | 46 | Q495Y8 | |
| DDEMLGPSAPGVDPS | 46 | P0CI01 | |
| SEMVTGEGSPSPEEE | 1341 | Q9BXM0 | |
| VDLEPGTMDSVRSGP | 66 | Q9BVA1 | |
| VDLEPGTMDSVRSGP | 66 | P68371 | |
| GPSVPSVILDEDGSM | 371 | Q9NZV5 | |
| LGPVSALGMTAPEED | 3526 | P22105 | |
| VDLEPGTMDSVRSGP | 66 | P07437 | |
| VEALSPMGLPGEEDS | 46 | Q9Y5U2 | |
| AMGRVDEEPTTLPSG | 301 | Q9Y4E1 | |
| PMDTSVLSEEGGEPF | 391 | Q12888 | |
| DEGGMVLTTLPLPSA | 181 | O95473 | |
| MEPSPAAGGLETTRL | 1 | Q99726 | |
| GMLLDDTISPFGTDP | 306 | O14948 | |
| EGLESSIAAEMPSIP | 616 | Q9H7P9 | |
| PGDMDEGDASLFTRP | 551 | Q03167 | |
| LGDEGALPSEMHLPS | 6 | Q9H0D2 | |
| SPVMPGIATSERGDE | 1036 | Q70EL1 | |
| DEELSPTFPGGEMAI | 631 | Q96SB3 | |
| DEGVVPGTTPLDMAT | 766 | P19838 |